BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 16, Issue 8
  • This Article
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (3974)
All Articles published online
The chart showing PDF series, HTML series, Figures (1-6) series, Tables (1-1) series.
Item 
Count 
PDF266
HTML1991
Figures (1-6)407
Tables (1-1)401
 Sum=3065
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse185
Download604
 Sum=789
Aug 15, 2024 (publication date) through Oct 31, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review
Copyright ©The Author(s) 2024.
World J Gastrointest Oncol. Aug 15, 2024; 16(8): 3397-3409
Published online Aug 15, 2024. doi: 10.4251/wjgo.v16.i8.3397
Table 1 List of c-Met inhibitors
Drug (alternative name)
Study
Phase
Crizotinib (PF0234I066)NCT00585I95I
Cabozantinib (XL184)NCT0I8664I0II
NCT0I708954II
NCT00940225II
Foretinib (GSKI363089)NCT0I068587I/II
Tepotinib (EMDI2I4063)NCT02864992II
Rilotumumab (AMG102)NCT02137343III
FiclatuzumabNCT03422536II
Tivantinib (ARQ197)NCT01244191III
Capmatinib (INC280, INCB28060)NCT0I324479I
NCT0I60336II
Full Size Table
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345